Using a murine model, Jia et al. [47] recently observed a dynamic effect of EGFR-TKIs on the tumor immune microenvironment from beneficial (early treatment) to immunosuppressive (later treatment) (Fig. 1; Table 2). This evidence concerns the gene EGFR and neoplasm.